Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 363,367 | 296,426 | 292,898 | 306,763 | 320,846 |
| Receivables | 195,707 | 207,066 | 200,752 | 202,657 | 211,949 |
| Inventories | 321,185 | 336,206 | 360,527 | 365,141 | 359,614 |
| TOTAL | $943,674 | $899,682 | $913,160 | $934,975 | $1,005,868 |
| Non-Current Assets | |||||
| PPE Net | 297,234 | 292,476 | 286,865 | 284,052 | 286,107 |
| Intangibles | 1,026,559 | 1,034,458 | 1,057,933 | 1,060,012 | 1,070,881 |
| Other Non-Current Assets | 223,423 | 215,540 | 204,136 | 171,909 | 168,414 |
| TOTAL | $1,547,216 | $1,542,474 | $1,548,934 | $1,515,973 | $1,525,402 |
| Total Assets | $2,490,890 | $2,442,156 | $2,462,094 | $2,450,948 | $2,531,270 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 48,694 | 61,691 | 46,010 | 66,999 | 62,990 |
| Accrued Expenses | 52,099 | 48,269 | 35,805 | 59,423 | 45,933 |
| Other current liabilities | 134,329 | 134,023 | 145,643 | 148,133 | 139,235 |
| TOTAL | $539,868 | $548,318 | $531,407 | $578,113 | $253,233 |
| Non-Current Liabilities | |||||
| Long Term Debt | 919,987 | 920,393 | 920,833 | 921,230 | 1,219,762 |
| Other Non-Current Liabilities | 63,605 | 66,071 | 68,066 | 68,194 | 89,964 |
| TOTAL | $1,039,571 | $1,044,665 | $1,048,387 | $1,051,999 | $1,371,177 |
| Total Liabilities | $1,579,439 | $1,592,983 | $1,579,794 | $1,630,112 | $1,624,410 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,471 | 46,810 | 48,177 | 48,037 | 50,237 |
| Common Shares | 468 | 467 | 482 | 482 | 502 |
| Retained earnings | 381,091 | 336,323 | 356,046 | 352,174 | 392,230 |
| Other shareholders' equity | -34,610 | -40,531 | -36,242 | -55,084 | -55,501 |
| TOTAL | $911,451 | $849,173 | $882,300 | $820,836 | $906,860 |
| Total Liabilities And Equity | $2,490,890 | $2,442,156 | $2,462,094 | $2,450,948 | $2,531,270 |